Clinical Study of Severe Influenza Virus Pneumonia That Caused Acute Respiratory Failure

Kurume Medical Journal

Volumn 48, Issue 4, 2001, Pages 273-279

  Kawayama, Tomotaka ^a,b   Fujiki, Rei ^a,b   Rikimaru, Toru ^b   Oizumi, Kotaro ^b  

^a Social Insurance Tagawa Hospital   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Influenza virus; Pneumonia; Respiratory failure

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ARTICLE; FEMALE; HUMAN; INFLUENZA; MALE; PROGNOSIS; RESPIRATORY FAILURE; VIRUS PNEUMONIA;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; PNEUMONIA, VIRAL; PROGNOSIS; RESPIRATORY INSUFFICIENCY;

EID: 0035757267     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.48.273     Document Type: Article

References (28)

1. Simonsen L, Clarke MJ, Williamson GD, Stoup DF, Arden NH et al. The impact of influenza epidemics on mortality: Introducing a severity index. Am J Public Health 1997; 87:1944-1950.
2. Barker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health 1986; 76:761-765.
3. Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982; 4:25-44.
4. Kashiwagi S, Ikematsu H, Hayashi J, Nomura H, Kajiyama W et al. An outbreak of influenza A (H3N2) in a hospital for the elderly with emphasis on pulmonary complications. Jpn J Med 1988; 27:177-182.
5. Perrotta DM, Decker M, and Glezen WP. Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol 1985; 122:468-476.
6. Monto AS, Gunn RA, Bandyk MG, and King CL. Prevention of Russian influenza by amantadine. JAMA 1979; 241:1003-1007.
7. Tominack RL, and Hadyden FG. Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infect Dis Clin North Am 1987; 1:459-478.
8. Sidwell RW, Bailey KW, Wong MH, and Huffman JH. In vitro and in vivo sensitivity of a non-mouse-adapted influenza A (Beijing) virus infection to amantadine and ribavirin. Chemotherapy 1995; 41:455-461.
9. Hayden FG, Osterhans ADME, Treanor JJ, Fleming DM, Aoki FY et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment influenzavirus infections. N Engl J Med 1997; 337:874-880.
10. Monto AS, Robinson DP, Herlocher ML, Minson JM Jr, Elliott MJ et al. Zanamivir in the prevention of influenza among healthy adults. A randomized controlled trial. JAMA 1999; 282:31-35.
11. Hers JF, Mulder J, Masurel N, Kuip L, and Tyrrell DAJ. Studies on the pathogenesis of influenza virus pneumonia in mice. J Path Bact 1962; 83:207-217.
12. Scott GH, and Sydiskis RJ. Responses of mice immunized with influenza virus by aerosol and parenteral routes. Infect Immun 1976; 13:696-703.
13. Peschke T, Bender A, Nain M, and Gemsa D. Role of macrophage cytokines in influenza A virus infection. Immunobiol 1993; 189:340-355.
14. Karupiah G, Chen JH, Mahalingam S, Nathan CF, and MacMicking JD. Rapid Interferon - dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J Exp Med 1998; 188:1541-1546.
15. Niederman MS, Bass JB Jr., Campbell GD, Fein AM, Grossman RF et al. Guidelines for the initial management of adult with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Resir Dis 1993; 148:1418-1426.
16. Ramphal R, Small PM, Shands JW, Fischlschweiger W, and Small PA Jr. Adherence of Pseudomonas aeruginosa to tracheal cells injured by influenza infection or by endotracheal intubation. Infect Immun 1980; 27:614-618.
17. Gremillion DH, and Crawford GE. Measles pneumonia in young adults. An analysis of 106 cases. Am J Med 1981; 71:539-542.
18. Ramsey PG, Fife KH, Hackman RC, Meyers JD, and Corey L. Herpes simplex virus pneumonia, clinical, virologie, and pathologic features in 20 patients. Ann Intern Med 1982; 97:813-820.
19. Conti JA, and Karetzky MS. Varicella pneumonia in the adult. N Eng J Med 1989; 86:475-478.
20. Oxford JS, Logan IS, and Potter CW. In vivo selection of an influenza A2 strain resistant to amantadine. Nature 1970; 226:82-83.
21. Hayden FG, and Hay AJ. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr Top Microbiol Immunol 1992; 176:119-130.
22. Embrey RP, and Geist LJ. Influenza A pneumonitis following treatment of acute cardiac allograft rejection with murine monoclonal anti-CD3 antibody (OKT3). Chest 1995; 108:1456-1459.
23. Monterar JSG, Russell JA, Lawson L, and Ruedy J. Acute respiratory failure secondary to Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a potential role for systemic corticosteroids. Chest 1989; 95:881-884.
24. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA et al. Early methylprednisolone treatment for septic and the adult respiratory distress syndrome. Chest 1987; 92:1032-1037.
25. Senderovitz T, and Viskum K. Corticosteroid and tuberculosis. Respir Med 1994; 88:561-565.
26. Dakhama A, Hegele RG, Laflamme G, Israel-Assayag E, and Cormier Y. Common respiratory viruses in lower airways of patients with acute hypersensitivity pneumonitis. Am J Respir Crit Care Med 1999; 159:1316-1322.
27. Leung KN, and Ada GL. Cell mediation delayed-type hypersensitivity in the lung of mice infected with an influenza A virus. Send J Immunol 1980; 12:393-400.
28. Hirota Y, Fedsom DS, and Masao K. Japan lagging in influenza jobs. Nature 1996; 380:18.